1. Home
  2. WTO vs ARTL Comparison

WTO vs ARTL Comparison

Compare WTO & ARTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WTO
  • ARTL
  • Stock Information
  • Founded
  • WTO 2008
  • ARTL 2011
  • Country
  • WTO China
  • ARTL United States
  • Employees
  • WTO N/A
  • ARTL N/A
  • Industry
  • WTO Consumer Electronics/Appliances
  • ARTL Biotechnology: Pharmaceutical Preparations
  • Sector
  • WTO Technology
  • ARTL Health Care
  • Exchange
  • WTO Nasdaq
  • ARTL Nasdaq
  • Market Cap
  • WTO 3.2M
  • ARTL 3.1M
  • IPO Year
  • WTO 2021
  • ARTL N/A
  • Fundamental
  • Price
  • WTO $1.01
  • ARTL $23.88
  • Analyst Decision
  • WTO
  • ARTL Strong Buy
  • Analyst Count
  • WTO 0
  • ARTL 2
  • Target Price
  • WTO N/A
  • ARTL $25.00
  • AVG Volume (30 Days)
  • WTO 51.8K
  • ARTL 1.9M
  • Earning Date
  • WTO 07-29-2025
  • ARTL 08-12-2025
  • Dividend Yield
  • WTO N/A
  • ARTL N/A
  • EPS Growth
  • WTO N/A
  • ARTL N/A
  • EPS
  • WTO N/A
  • ARTL N/A
  • Revenue
  • WTO $32,309,502.00
  • ARTL N/A
  • Revenue This Year
  • WTO N/A
  • ARTL N/A
  • Revenue Next Year
  • WTO N/A
  • ARTL N/A
  • P/E Ratio
  • WTO N/A
  • ARTL N/A
  • Revenue Growth
  • WTO 47.36
  • ARTL N/A
  • 52 Week Low
  • WTO $0.75
  • ARTL $4.92
  • 52 Week High
  • WTO $622.50
  • ARTL $28.60
  • Technical
  • Relative Strength Index (RSI)
  • WTO 47.48
  • ARTL 72.07
  • Support Level
  • WTO $0.75
  • ARTL $9.11
  • Resistance Level
  • WTO $1.02
  • ARTL $28.60
  • Average True Range (ATR)
  • WTO 0.06
  • ARTL 4.19
  • MACD
  • WTO 0.04
  • ARTL 1.92
  • Stochastic Oscillator
  • WTO 90.14
  • ARTL 79.31

About WTO UTime Limited

UTime Ltd is engaged in the design, development, production, sales and brand operation of mobile phones, accessories and related consumer electronics. It also provides Electronics Manufacturing Services (EMS), including Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services, for renowned brands. The company operates in China and its products are sold globally, including Mexico, Brazil, the United States, and other emerging markets in South Asia and Africa as well as Europe. It has two in-house brands, UTime, known as its middle-to-high end label and targets middle class consumers from emerging markets; and Do, as its low- to mid-end brand, is positioned to the grassroots consumers and price-sensitive consumers in emerging markets.

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

Share on Social Networks: